ENTX (Entera Bio Ltd) Bozor qiymatining balans qiymatiga nisbati

enterabio.com (ENTX) kompaniyasining rasmiy ramzlari

Entera Bio Ltd. (ENTX) og'iz orqali oqsil yetkazib berish tizimlarini ishlab chiqish uchun yetakchi bioximiklarni ishga olmoqda, mutaxassislarga ijodiy erkinlik va istiqbolli bonuslar taklif qilmoqda. Jamoaga Daniel Levkovich rahbarlik qiladi, uning aksiyadorlar orasidagi nufuzi innovatsiyalarni joriy etishdagi tajribasiga va yirik korporatsiyalar bilan aloqalariga asoslangan. Biznes ishlab chiqarish va sinovlarning to'liq autsorsingiga tayanadi, bu esa 19.27 ni tashkil etadi. Ushbu kunlik narxlar grafigi aktivning narx harakatlarini batafsil vizuallashtiradi.

ENTX enterabio.com: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 27.10.2026 oraligʻida

Entera Bio Ltd. (ENTX) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari enterabio.com|ENTX - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Entera Bio Corp|ENTX - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Entera Bio|ENTX - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati enterabio.com|ENTX - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Entera Bio Ltd.|ENTX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati enterabio.com|ENTX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Entera Bio Corp
Kompaniyaning dastlabki tahlili:Entera Bio Ltd - ENTX
enterabio.com original mahsuloti

Ushbu koeffitsient kompaniyaning bozor qiymati va uning sof aktivlari o'rtasidagi nisbatni belgilaydi. Investorlar ushbu metrikadan biznesning haqiqiy balans hisoboti nisbatida to'langan premiumni baholash uchun foydalanadilar. Bozor qiymatining kitob kapitaliga nisbatini tahlil qilish spekulyativ pufaklarni aniqlash imkonini beradi. Entera Bio Ltd. (ENTX) uchun joriy baholash asosan klinik sinovlarning muvaffaqiyati bilan belgilanadi. Keyingi o'sish uchun yangi tijorat triggerlari talab etiladi.

Asosiy raqobatchilar

Kapitallashuvning sof aktivlarga nisbati Haleon plc|KVUE (kenvue.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TBPH (Theravance Biopharma Inc)|AQST: Bozor qiymatining balans qiymatiga nisbati|SCPH - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tectonic TECX|TNXP - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati BHST (BioHarvest)|Bozor qiymatining balans qiymatiga koeffitsiyenti EXOZ|Oramed Pharmaceuticals (ORMP) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ipatherapeutics.com (HYFT)|ABVC: Bozor kapitallashuvining balans qiymatiga nisbati|Cumberland Pharmaceuticals Inc - Bozor qiymatining balans qiymatiga koeffitsiyenti|Quantum BioPharma Limited (QNTM) - Bozor qiymatining balans qiymatiga nisbati|FibroGen Corporation (FGEN) - Kapitallashuvning balans qiymatiga nisbati|TELO - Kapitallashuvning sof aktivlarga nisbati|Rani Therapeutics Holdings, Inc. (RANI) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati SNYR (Synergy CHC Corp.)|Bozor qiymatining balans qiymatiga koeffitsiyenti RLYB|Lexaria Bioscience (LEXX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Pulmatrix Corporation (PULM)|Bozor kapitallashuvining balans qiymatiga nisbati PTHL (Pheton Holdings)|APM - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Lyra Therapeutics (LYRA)|IBO - Balans qiymatiga nisbatan bozor qiymati|tnfpharma.com (TNFA) - Bozor kapitallashuvining balans qiymatiga nisbati|cbdMD (YCBD) - Bozor qiymatining balans qiymatiga nisbati|PRFX: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi CYTO|Lipella Pharmaceuticals, Inc. - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti OptiNose Inc OPTN|Kapitallashuvning sof aktivlarga nisbati Pieris|Procaps Group Corp - Balans qiymatiga nisbatan bozor qiymati|PTPI - Bozor qiymatining balans qiymatiga nisbati|qlsyy.net (QLI) - Bozor qiymatining balans qiymatiga nisbati|SLRN - Kapitallashuvning sof aktivlarga nisbati|TFF Pharmaceuticals Inc. (TFFP) - Bozor kapitallashuvining balans qiymatiga multiplikatori